KG&L Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $536K | Buy |
14,008
+1,353
| +11% | +$51.8K | 0.16% | 111 |
|
|
2025
Q1 | $488K | Sell |
12,655
-376
| -3% | -$14.5K | 0.16% | 124 |
|
|
2024
Q4 | $441K | Sell |
13,031
-3,654
| -22% | -$124K | 0.14% | 129 |
|
|
2024
Q3 | $679K | Buy |
16,685
+5,104
| +44% | +$208K | 0.22% | 98 |
|
|
2024
Q2 | $444K | Sell |
11,581
-33,002
| -74% | -$1.27M | 0.15% | 131 |
|
|
2024
Q1 | $1.91M | Sell |
44,583
-3,662
| -8% | -$157K | 0.76% | 29 |
|
|
2023
Q4 | $1.79M | Sell |
48,245
-1,106
| -2% | -$41K | 0.75% | 28 |
|
|
2023
Q3 | $1.79M | Sell |
49,351
-759
| -2% | -$27.5K | 0.86% | 25 |
|
|
2023
Q2 | $1.79M | Sell |
50,110
-190
| -0.4% | -$6.77K | 0.86% | 24 |
|
|
2023
Q1 | $1.79M | Buy |
50,300
+1,636
| +3% | +$58.2K | 0.94% | 24 |
|
|
2022
Q4 | $1.71M | Buy |
+48,664
| New | +$1.71M | 0.99% | 23 |
|
|
2022
Q3 | – | Sell |
-23,767
| Closed | -$1.29M | – | 131 |
|
|
2022
Q2 | $1.29M | Buy |
23,767
+78
| +0.3% | +$4.24K | 0.7% | 35 |
|
|
2022
Q1 | $1.29M | Buy |
23,689
+180
| +0.8% | +$9.8K | 0.54% | 49 |
|
|
2021
Q4 | $1.3M | Sell |
23,509
-634
| -3% | -$35K | 0.52% | 56 |
|
|
2021
Q3 | $1.15M | Sell |
24,143
-3,394
| -12% | -$162K | 0.51% | 55 |
|
|
2021
Q2 | $1.37M | Buy |
27,537
+1,095
| +4% | +$54.5K | 0.62% | 41 |
|
|
2021
Q1 | $1.18M | Buy |
26,442
+7,476
| +39% | +$334K | 0.59% | 42 |
|
|
2020
Q4 | $872K | Buy |
18,966
+1,524
| +9% | +$70.1K | 0.48% | 51 |
|
|
2020
Q3 | $820K | Buy |
17,442
+5,834
| +50% | +$274K | 0.51% | 48 |
|
|
2020
Q2 | $591K | Buy |
11,608
+450
| +4% | +$22.9K | 0.45% | 53 |
|
|
2020
Q1 | $528K | Buy |
11,158
+5,496
| +97% | +$260K | 0.53% | 51 |
|
|
2019
Q4 | $332K | Buy |
5,662
+504
| +10% | +$29.6K | 0.28% | 71 |
|
|
2019
Q3 | $275K | Buy |
5,158
+1,004
| +24% | +$53.5K | 0.25% | 75 |
|
|
2019
Q2 | $207K | Buy |
+4,154
| New | +$207K | 0.2% | 84 |
|